Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.810
+0.020 (0.72%)
Jul 14, 2026, 10:11 AM EDT - Market open
Nkarta Market Cap
Nkarta has a market cap or net worth of $201.04 million as of July 14, 2026. Its market cap has increased by 59.17% in one year.
Market Cap
201.04M
Enterprise Value
44.18M
1-Year Change
59.17%
Ranking
Category
Stock Price
$2.81
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $201.04M, a decrease of -86.27%. That is a compound annual growth rate of -28.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 212.49M | 61.71% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision BioSciences | 226.03M |
| Camp4 Therapeutics | 224.84M |
| Codexis | 220.88M |
| Minerva Neurosciences | 219.90M |
| NovaBridge Biosciences | 219.73M |
| Cellectis | 214.98M |
| Whitehawk Therapeutics | 213.52M |
| Atrium Therapeutics | 213.14M |